Samsung Biologics Wins Subcutaneous Drug Deals, Eyes New Growth Engine
Samsung Biologics (207940.KS) will produce the drug substance (DS) for AstraZeneca’s Saphnelo subcutaneous (SC) injection, a treatment for…
Samsung Biologics Wins Subcutaneous Drug Deals, Eyes New Growth Engine
Samsung Biologics (207940.KS) will produce the drug substance (DS) for AstraZeneca’s Saphnelo subcutaneous (SC) injection, a treatment for…
Samsung Biologics Wins Subcutaneous Drug Deals, Eyes New Growth Engine
Samsung Biologics (207940.KS) will produce the drug substance (DS) for AstraZeneca’s Saphnelo subcutaneous (SC) injection, a treatment for…
K-Bio Courts Big Pharma With AI; Celltrion Books 150 Meetings
“After Cenobamate, our epilepsy treatment, was commercialized, one of the answers we reached after agonizing over how to…
K-Bio Courts Big Pharma With AI; Celltrion Books 150 Meetings
“After Cenobamate, our epilepsy treatment, was commercialized, one of the answers we reached after agonizing over how to…